BGI Genomics Co., Ltd. (SHE:300676)

China flag China · Delayed Price · Currency is CNY
39.98
-0.02 (-0.05%)
May 19, 2026, 10:25 AM CST
Market Cap15.35B -16.5%
Revenue (ttm)3.84B +3.4%
Net Income-573.48M
EPS-1.37
Shares Out383.85M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,558,975
Average Volume7,646,994
Open40.95
Previous Close40.00
Day's Range39.68 - 40.95
52-Week Range38.17 - 65.00
Beta0.76
RSI44.69
Earnings DateApr 25, 2026

About BGI Genomics

BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected wit... [Read more]

Sector Healthcare
Founded 1999
Employees 3,580
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300676
Full Company Profile

Financial Performance

In 2025, BGI Genomics's revenue was 3.71 billion, a decrease of -4.18% compared to the previous year's 3.87 billion. Losses were -616.66 million, -31.69% less than in 2024.

Financial Statements